What was Indegene's revenue in Q4 FY26?

Indegene reported revenue of ₹1,001 Cr in Q4 FY26, a +32.8% change year-over-year.

Did Indegene management deliver on previous promises?

Scorecard data is being built as historical quarters are processed.

Indegene Q4 FY26 Research Workspace: Revenue ₹1,001 Cr (+32.8%)

Q: What guidance did Indegene management give?

EBITDA margin recovery to historical levels by H2 FY27: Management expects adjusted EBITDA margins to revert to earlier higher levels in the second half of FY27 as current investments get absorbed.

Revenue ₹1,001 Cr +32.8%

EBITDA ₹189 Cr +23.2%

PAT ₹80 Cr -1.4%

EBITDA Margin 18.9% -150bps

Duration 62 min

Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Indegene delivered a landmark Q4 FY26 with revenue crossing ₹1,000 crore for the first time, up 32.8% YoY, and full-year revenue of ₹3,515 crore (+23.6% YoY). Growth was driven by strong deal momentum, including a tectonic engagement with the largest customer in Germany and a $10M+ ACV omni-channel win. Adjusted EBITDA margin contracted ~150bps due to planned investments in AI, talent, and acquisitions (Bioarm, Cake), but management expects margins to recover to historical levels by H2 FY27. PAT was impacted by a one-time ₹20.3 crore provision for a US class action settlement. The pipeline entering FY27 is stronger and more diversified, with GenAI solutions gaining traction across commercial and medical segments. Key risk: margin recovery may be delayed if investment intensity persists beyond planned timelines.

Risks4 trackedTranscriptfull text

Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Margin recovery may be delayed if investments persist

View Risks →

≡Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Revenue per employee $75,000

+$9,000 YoY

Increased from $66,000 last year, driven by AI-led productivity and outcome-based pricing.

Active customers 91

+18 YoY

Grew from 73 last year, with customers >$1M revenue increasing from 41 to 53.

DSO (days sales outstanding) 63 days

-9 days YoY

Improved from 72 days last year, driving strong operating cash flow of ₹658 crore.

Top 20 customer revenue ₹2,520 crore

+₹240 crore YoY

Grew from ₹2,280 crore, with one customer expected to cross $50M in FY27.

Fast read

Guidance and risk preview

Top guidance EBITDA margin recovery to historical levels by H2 FY27

Management expects adjusted EBITDA margins to revert to earlier higher levels in the second half of FY27 as current investments get absorbed.

Top risk Margin recovery may be delayed if investments persist

Management plans to reinvest any margin upside above the historical range, which could delay margin expansion beyond H2 FY27.